H Brent Solvason

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi request reprint Predictors of response in anxiety disorders
    H Brent Solvason
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA 94305 5723, USA
    Psychiatr Clin North Am 26:411-33. 2003
  2. ncbi request reprint Psychological versus biological clinical interpretation: a patient with prion disease
    H Brent Solvason
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, CA 94305 5723, USA
    Am J Psychiatry 159:528-37. 2002
  3. ncbi request reprint Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study
    Boadie W Dunlop
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1841 Clifton Road NE, Atlanta, GA 30307, USA
    J Clin Psychopharmacol 27:614-9. 2007
  4. ncbi request reprint A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants
    Charles DeBattista
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine Stanford, CA 94305 5723, USA
    J Clin Psychopharmacol 23:27-30. 2003
  5. ncbi request reprint A prospective trial of modafinil as an adjunctive treatment of major depression
    Charles DeBattista
    Stanford University School of Medicine, Depression Research Clinic, Stanford, CA 94305 5723, USA
    J Clin Psychopharmacol 24:87-90. 2004
  6. ncbi request reprint Cortisol circadian rhythm alterations in psychotic major depression
    Jennifer Keller
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305 5723, USA
    Biol Psychiatry 60:275-81. 2006
  7. pmc Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depression
    Jennifer Keller
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Rd, Stanford, CA 94305 5723, USA
    Am J Psychiatry 165:872-80. 2008
  8. ncbi request reprint Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial
    H Brent Solvason
    Department of Psychiatry, University of Pennsylvania, 3535 Market Street, Philadelphia, PA 19014, USA
    Biol Psychiatry 62:1208-16. 2007

Detail Information

Publications8

  1. ncbi request reprint Predictors of response in anxiety disorders
    H Brent Solvason
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA 94305 5723, USA
    Psychiatr Clin North Am 26:411-33. 2003
    ..However, it should be emphasized that such an approach has not been empirically demonstrated in a rigorous experimental context at this time...
  2. ncbi request reprint Psychological versus biological clinical interpretation: a patient with prion disease
    H Brent Solvason
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, CA 94305 5723, USA
    Am J Psychiatry 159:528-37. 2002
  3. ncbi request reprint Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study
    Boadie W Dunlop
    Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1841 Clifton Road NE, Atlanta, GA 30307, USA
    J Clin Psychopharmacol 27:614-9. 2007
    ..Previous studies suggest that adjunctive modafinil treatment provides benefit for patients with depression with significant sleepiness and fatigue...
  4. ncbi request reprint A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants
    Charles DeBattista
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine Stanford, CA 94305 5723, USA
    J Clin Psychopharmacol 23:27-30. 2003
    ..This prospective, open-label trial supports the use of bupropion SR in the augmentation of SSRIs and venlafaxine. Placebo controlled trials should be completed to further evaluate the efficacy of this strategy...
  5. ncbi request reprint A prospective trial of modafinil as an adjunctive treatment of major depression
    Charles DeBattista
    Stanford University School of Medicine, Depression Research Clinic, Stanford, CA 94305 5723, USA
    J Clin Psychopharmacol 24:87-90. 2004
    ..Modafinil may be a useful and a well-tolerated adjunctive agent to standard antidepressants in the treatment of major depression...
  6. ncbi request reprint Cortisol circadian rhythm alterations in psychotic major depression
    Jennifer Keller
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305 5723, USA
    Biol Psychiatry 60:275-81. 2006
    ..There are limited data on cortisol levels during specific times of the day...
  7. pmc Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depression
    Jennifer Keller
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Rd, Stanford, CA 94305 5723, USA
    Am J Psychiatry 165:872-80. 2008
    ..The purpose of the present study was to examine differences in hippocampal and amygdalar volumes in patients with depression subtypes relative to healthy comparison subjects...
  8. ncbi request reprint Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial
    H Brent Solvason
    Department of Psychiatry, University of Pennsylvania, 3535 Market Street, Philadelphia, PA 19014, USA
    Biol Psychiatry 62:1208-16. 2007
    ..We tested whether transcranial magnetic stimulation (TMS) over the left dorsolateral prefrontal cortex (DLPFC) is effective and safe in the acute treatment of major depression...